This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Synovis Life 4Q Profit Doubles

ST. PAUL, Minn. (AP) ¿ Medical device maker Synovis Life Technologies Inc. said Wednesday its profit doubled during its fiscal fourth quarter on a boost in sales and a gain from investments.

The company earned $3.8 million, or 33 cents per share, compared with profit of $1.9 million, or 15 cents per share, during the same period a year prior. Revenue rose 18 percent to $15 million from $12.7 million.

Excluding investment gains and other items, the company said it earned 5 cents per share, in line with estimates from analysts polled by Thomson Reuters.

During the quarter ended Oct. 31, Peri-Strip sales were flat at $4.7 million. The product is used to control bleeding and leakage in anti-obesity surgery. Meanwhile, tissue patch product sales rose 9 percent to $3.9 million.

For the full fiscal year, the company earned $2.7 million, or 23 cents per share, down from profit of $11.5 million, or 90 cents per share, a year prior. Revenue rose to $58.2 million from $49.8 million.

Shares of Synovis rose 29 cents, or 2.4 percent, to $12.59 in afternoon trading. The stock has traded between $11.16 and $21.71 over the past 52 weeks.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs